股本结构
单位：万股
| 公告日期 | 2024-04-12 | 2024-03-14 | 2024-03-14 | 2023-12-19 | 2023-12-19 | 2023-11-08 |
|---|---|---|---|---|---|---|
| 证券总股本 | 2530.77 | 2529.55 | 2528.12 | 2526.81 | 2526.78 | 2526.74 |
| 普通股本 | 2530.77 | 2529.55 | 2528.12 | 2526.81 | 2526.78 | 2526.74 |
| 优先股 | 未披露 | 未披露 | 220.00 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-03-26 | 2024-03-13 | 2023-12-31 | 2023-12-11 | 2023-11-30 | 2023-11-07 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-04-12 | 2530.77 | 未披露 | 定期报告 | 2024-03-26 |
| 2024-03-14 | 2529.55 | 未披露 | 定期报告 | 2024-03-13 |
| 2024-03-14 | 2528.12 | 220.00 |
更多>>
From December 31, 2022 to December 31, 2023
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock, and pre-funded warrants, net of issuance cost of $6,351
|
2023-12-31 |
| 2023-12-19 | 2526.81 | 未披露 | 定期报告 | 2023-12-11 |
| 2023-12-19 | 2526.78 | 未披露 | 定期报告 | 2023-11-30 |
| 2023-11-08 | 2526.74 | 未披露 | 定期报告 | 2023-11-07 |
| 2023-11-08 | 2526.48 | 220.00 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock under Employee Stock Purchase Plan
|
2023-09-30 |
| 2023-08-08 | 2525.07 | 未披露 | 定期报告 | 2023-08-07 |
| 2023-08-08 | 2524.20 | 220.00 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common stock, and pre-funded warrants, net of issuance cost of $6,351
Issuance of common stock resulting from vesting of restricted stock units
|
2023-06-30 |
| 2023-06-20 | 2392.08 | 未披露 |
更多>>
Common stock offered by the company 7,181,409 shares
|
2023-06-21 |
| 2023-05-31 | 1673.94 | 未披露 |
更多>>
Verastem Oncology announced that it will effect a 1-for-12 reverse stock split of its issued and outstanding common stock.
|
2023-06-01 |
| 2023-05-31 | 20087.26 | 未披露 | 定期报告 | 2023-05-31 |
| 2023-05-09 | 20086.14 | 未披露 | 定期报告 | 2023-05-08 |
| 2023-05-09 | 20054.10 | 100.00 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of Series B Convertible Preferred Stock, net of issuance costs of $1,901 and preferred stock tranche liability of $6,940
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock under Employee Stock Purchase Plan
|
2023-03-31 |
| 2023-03-23 | 20075.24 | 未披露 | 定期报告 | 2023-03-20 |
| 2023-03-14 | 20067.80 | 未披露 | 定期报告 | 2023-03-13 |
| 2023-03-14 | 20054.10 | 100.00 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of Series A Preferred Stock in exchange for common stock
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from at-the-market transactions, net
|
2022-12-31 |
| 2022-11-03 | 21009.09 | 未披露 | 定期报告 | 2022-11-02 |
| 2022-11-03 | 21008.40 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock resulting from at-the-market transactions, net
Issuance of common stock resulting from exercise of stock options
|
2022-09-30 |
| 2022-08-08 | 18780.76 | 未披露 | 定期报告 | 2022-08-05 |
| 2022-08-08 | 18761.30 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock resulting from at-the-market transactions, net
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units
|
2022-06-30 |
| 2022-05-09 | 18636.12 | 未披露 | 定期报告 | 2022-05-06 |
| 2022-05-09 | 18633.00 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Issuance of common stock resulting from at-the-market transactions, net
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock under Employee Stock Purchase Plan
|
2022-03-31 |
| 2022-03-28 | 18632.96 | 未披露 | 定期报告 | 2022-03-25 |
| 2022-04-01 | 18629.53 | 未披露 | 定期报告 | 2022-03-15 |
| 2022-03-28 | 18528.60 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Conversion of Notes into common stock
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from at-the-market transactions, net
|
2021-12-31 |
| 2021-11-04 | 18218.60 | 未披露 | 定期报告 | 2021-11-03 |
| 2021-11-04 | 18215.50 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock resulting from exercise of stock options
|
2021-09-30 |
| 2021-08-02 | 18075.83 | 未披露 | 定期报告 | 2021-07-30 |
| 2021-08-02 | 17207.74 | 未披露 | 定期报告 | 2021-06-30 |
| 2021-05-11 | 17191.93 | 未披露 | 定期报告 | 2021-05-10 |
| 2021-05-11 | 17173.10 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock under Employee Stock Purchase Plan
|
2021-03-31 |
| 2021-04-08 | 17166.57 | 未披露 | 定期报告 | 2021-03-15 |
| 2021-03-18 | 17045.60 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Conversion of Notes into common stock
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from at-the-market transactions, net of issuance costs of $55
Issuance of common stock resulting from private investment in public equity offering, net of issuance costs of $6,171
|
2020-12-31 |
| 2020-11-09 | 16977.44 | 未披露 | 定期报告 | 2020-11-06 |
| 2020-11-09 | 16954.04 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock resulting from vesting of restricted stock units
|
2020-09-30 |
| 2020-08-10 | 16953.23 | 未披露 | 定期报告 | 2020-08-07 |
| 2020-08-10 | 16933.80 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock resulting from at-the-market transactions, net of issuance costs of $55
|
2020-06-30 |
| 2020-05-07 | 16253.40 | 未披露 | 定期报告 | 2020-05-06 |
| 2020-05-07 | 16235.60 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock resulting from private investment in public equity offering, net of issuance costs of $6,171
Issuance of common stock under Employee Stock Purchase Plan
Conversion of 2019 Notes into common stock
|
2020-03-31 |
| 2020-03-23 | 15860.49 | 未披露 | 定期报告 | 2020-03-15 |
| 2020-03-11 | 14841.04 | 未披露 |
更多>>
On March 3, 2020, the Company sold 46,511,628 shares of Common Stock at a purchase price of $2.15 per share for aggregate gross proceeds of approximately $100.0 million, before deducting fees to the placement agents and other offering expenses payable by the Company pursuant to a securities purchase agreement.
|
2020-03-11 |
| 2020-02-28 | 9140.28 | 未披露 | 定期报告 | 2020-02-27 |
| 2020-03-11 | 8011.80 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Conversion of Notes into common stock
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock resulting from exercise of stock options
|
2019-12-31 |
| 2019-10-30 | 7434.97 | 未披露 | 定期报告 | 2019-10-30 |
| 2019-10-30 | 7431.37 | 未披露 |
更多>>
from June 30, 2019 to September 30, 2019
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock resulting from exercise of stock options
|
2019-09-30 |
| 2019-08-01 | 7414.07 | 未披露 | 定期报告 | 2019-08-01 |
| 2019-05-09 | 7387.69 | 未披露 |
更多>>
from December 31, 2018 to March 31, 2019
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units and payment of tax withholdings
|
2019-03-31 |
| 2019-04-08 | 7387.69 | 未披露 | 定期报告 | 2019-03-21 |
| 2019-04-08 | 7386.50 | 未披露 | 定期报告 | 2019-02-28 |
| 2019-03-12 | 7380.64 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Issuance of common stock resulting from follow-on offering, net of issuance costs of $361
Issuance of common stock resulting from at-the-market transactions, net of issuance costs of $0
Issuance of common stock resulting from exercise of stock options
|
2018-12-31 |
| 2018-11-19 | 7379.13 | 未披露 | 定期报告 | 2018-11-12 |
| 2018-11-07 | 7374.02 | 未披露 | 定期报告 | 2018-11-02 |
| 2018-11-19 | 7370.34 | 未披露 | 定期报告 | 2018-09-30 |
| 2018-08-08 | 7359.23 | 未披露 | 定期报告 | 2018-08-06 |
| 2018-07-24 | 7357.97 | 未披露 | 定期报告 | 2018-06-30 |
| 2018-05-03 | 5661.27 | 未披露 | 定期报告 | 2018-04-30 |
| 2018-05-03 | 5096.80 | 未披露 | 定期报告 | 2018-03-31 |
| 2018-04-10 | 5096.80 | 未披露 | 定期报告 | 2018-03-29 |
| 2018-04-10 | 5080.09 | 未披露 | 定期报告 | 2018-02-28 |
| 2018-03-13 | 5080.10 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Issuance of common stock resulting from follow-on offering, net of issuance costs of $324
Issuance of common stock resulting from at-the-market transactions, net of issuance costs of $112
Issuance of common stock resulting from exercise of stock options
|
2017-12-31 |
| 2017-11-07 | 4048.94 | 未披露 | 定期报告 | 2017-11-06 |
| 2017-11-07 | 3994.50 | 未披露 | 定期报告 | 2017-09-30 |
| 2017-08-08 | 3699.24 | 未披露 | 定期报告 | 2017-08-04 |
| 2017-08-08 | 3699.20 | 未披露 | 定期报告 | 2017-06-30 |
| 2017-05-10 | 3699.24 | 未披露 | 定期报告 | 2017-05-08 |
| 2017-05-10 | 3699.20 | 未披露 | 定期报告 | 2017-03-31 |
| 2017-03-23 | 3699.24 | 未披露 |
更多>>
from December 31, 2015 to December 31, 2016
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units and payment of tax withholdings
|
2016-12-31 |
| 2016-11-07 | 3699.24 | 未披露 | 定期报告 | 2016-10-31 |
| 2016-11-07 | 3699.20 | 未披露 | 定期报告 | 2016-09-30 |
| 2016-05-09 | 3699.24 | 未披露 | 定期报告 | 2016-05-02 |
| 2016-05-09 | 3699.20 | 未披露 | 定期报告 | 2016-03-31 |
| 2016-03-03 | 3699.24 | 未披露 | 定期报告 | 2016-02-22 |
| 2016-03-03 | 3694.13 | 未披露 |
更多>>
From December 31, 2014 to December 31, 2015
Issuance of common stock resulting from follow-on offering
Issuance of common stock resulting from at-the-market transactions, net of issuance costs of $53
Vesting of restricted stock
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units and payment of tax withholdings
|
2015-12-31 |
| 2015-11-09 | 3693.48 | 未披露 | 定期报告 | 2015-10-29 |
| 2015-11-09 | 3693.50 | 未披露 | 定期报告 | 2015-09-30 |
| 2015-08-10 | 3689.74 | 未披露 | 定期报告 | 2015-08-05 |
| 2015-08-10 | 3685.40 | 未披露 | 定期报告 | 2015-06-30 |
| 2015-05-11 | 3653.67 | 未披露 | 定期报告 | 2015-05-06 |
| 2015-05-11 | 3615.20 | 未披露 | 定期报告 | 2015-03-31 |
| 2015-03-10 | 3595.51 | 未披露 |
更多>>
In January 2015, we completed a follow-on offering in which we sold 8,337,500 shares of our common stock to the public at a price of $6.50 per share, including 1,087,500 shares issued pursuant to the exercise of the underwriters' option to purchase additional shares. The net proceeds from this offering were approximately $50.9 million, after deducting underwriting discounts and commissions.
|
2015-02-27 |
| 2015-03-10 | 2725.94 | 未披露 |
更多>>
from December 31, 2013 to December 31, 2014
Issuance of common stock, net of issuance costs of $43
Vesting of restricted stock
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units and payment of tax withholdings
Shares issued for technology rights
|
2014-12-31 |
| 2014-10-30 | 2589.44 | 未披露 | 定期报告 | 2014-10-23 |
| 2014-10-30 | 2587.80 | 未披露 | 定期报告 | 2014-09-30 |
| 2014-08-07 | 2584.23 | 未披露 | 定期报告 | 2014-07-31 |
| 2014-08-07 | 2572.20 | 未披露 | 定期报告 | 2014-06-30 |
| 2014-05-08 | 2583.49 | 未披露 | 定期报告 | 2014-04-30 |
| 2014-05-08 | 2561.00 | 未披露 | 定期报告 | 2014-03-31 |
| 2014-04-07 | 2582.76 | 未披露 | 定期报告 | 2014-03-28 |
| 2014-03-06 | 2582.29 | 未披露 | 定期报告 | 2014-02-28 |
| 2014-03-06 | 2532.80 | 未披露 |
更多>>
from December 31, 2012 to December 31, 2013
Issuance of common stock, net of issuance costs of $235
Vesting of restricted stock
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units and payment of tax withholdings
|
2013-12-31 |
| 2013-11-12 | 2564.77 | 未披露 | 定期报告 | 2013-11-07 |
| 2013-11-12 | 2521.40 | 未披露 | 定期报告 | 2013-09-30 |
| 2013-08-13 | 2559.40 | 未披露 | 定期报告 | 2013-07-31 |
| 2013-08-13 | 2079.40 | 未披露 | 定期报告 | 2013-06-30 |
| 2013-04-25 | 2128.93 | 未披露 | 定期报告 | 2013-04-18 |
| 2013-05-09 | 2064.00 | 未披露 | 定期报告 | 2013-03-31 |
| 2013-03-26 | 2115.25 | 未披露 | 定期报告 | 2013-02-28 |
| 2013-02-01 | 2111.12 | 未披露 | 定期报告 | 2013-01-25 |
| 2013-03-26 | 2036.42 | 未披露 |
更多>>
from December 31, 2011 to December 31, 2012
Conversion of redeemable convertible preferred stock into common stock
Issuance of common stock, net of issuance costs of $1,984
Issuance of common stock in exchange for license
Vesting of restricted stock
Issuance of common stock resulting from exercise of stock options
In January 2012, the Company's board of directors and stockholders approved a one-for-3.5 reverse stock split of the Company's common stock. The reverse stock split became effective on January 10, 2012.
|
2012-12-31 |
| 2012-11-13 | 2125.51 | 未披露 | 定期报告 | 2012-11-09 |
| 2012-11-13 | 2125.50 | 未披露 | 定期报告 | 2012-09-30 |
| 2012-08-13 | 2125.11 | 未披露 | 定期报告 | 2012-08-10 |
| 2012-08-13 | 2105.90 | 未披露 | 定期报告 | 2012-06-30 |
| 2012-05-14 | 2105.91 | 未披露 | 定期报告 | 2012-05-04 |
| 2012-05-14 | 1979.10 | 未披露 | 定期报告 | 2012-03-31 |
| 2012-03-30 | 2105.91 | 未披露 | 定期报告 | 2012-03-15 |
| 2012-01-27 | 2023.41 | 未披露 |
更多>>
1.the automatic conversion of all outstanding shares of our preferred stock into an aggregate of 11,740,794 shares of our common stock upon the closing of this offering;
2.all information in this prospectus gives effect to the one-for-3.5 reverse stock split of our common stock that was effected on January 10, 2012.
|
2012-01-27 |
| 2012-03-30 | 155.90 | 4109.30 |
更多>>
from December 31, 2010 to December 31, 2011
Issuance of Series A redeemable convertible preferred stock
Issuance of Series B redeemable convertible preferred stock, net of offering costs of $113
Accretion of redeemable convertible preferred stock to redemption value
Vesting of restricted stock
|
2011-12-31 |
From December 31, 2022 to December 31, 2023
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock, and pre-funded warrants, net of issuance cost of $6,351
From June 30, 2023 to September 30, 2023
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock under Employee Stock Purchase Plan
From March 31, 2023 to June 30, 2023
Issuance of common stock, and pre-funded warrants, net of issuance cost of $6,351
Issuance of common stock resulting from vesting of restricted stock units
Common stock offered by the company 7,181,409 shares
Verastem Oncology announced that it will effect a 1-for-12 reverse stock split of its issued and outstanding common stock.
From December 31, 2022 to March 31, 2023
Issuance of Series B Convertible Preferred Stock, net of issuance costs of $1,901 and preferred stock tranche liability of $6,940
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock under Employee Stock Purchase Plan
From December 31, 2021 to December 31, 2022
Issuance of Series A Preferred Stock in exchange for common stock
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from at-the-market transactions, net
From June 30, 2022 to September 30, 2022
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock resulting from at-the-market transactions, net
Issuance of common stock resulting from exercise of stock options
From March 31, 2022 to June 30, 2022
Issuance of common stock resulting from at-the-market transactions, net
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units
From December 31, 2021 to March 31, 2022
Issuance of common stock resulting from at-the-market transactions, net
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock under Employee Stock Purchase Plan
From December 31, 2020 to December 31, 2021
Conversion of Notes into common stock
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from at-the-market transactions, net
From June 30, 2021 to September 30, 2021
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock resulting from exercise of stock options
From December 31, 2020 to March 31, 2021
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock under Employee Stock Purchase Plan
From December 31, 2019 to December 31, 2020
Conversion of Notes into common stock
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from at-the-market transactions, net of issuance costs of $55
Issuance of common stock resulting from private investment in public equity offering, net of issuance costs of $6,171
From June 30, 2020 to September 30, 2020
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock resulting from vesting of restricted stock units
From March 31, 2020 to June 30, 2020
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock resulting from at-the-market transactions, net of issuance costs of $55
From December 31, 2019 to March 31, 2020
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock resulting from private investment in public equity offering, net of issuance costs of $6,171
Issuance of common stock under Employee Stock Purchase Plan
Conversion of 2019 Notes into common stock
On March 3, 2020, the Company sold 46,511,628 shares of Common Stock at a purchase price of $2.15 per share for aggregate gross proceeds of approximately $100.0 million, before deducting fees to the placement agents and other offering expenses payable by the Company pursuant to a securities purchase agreement.
From December 31, 2018 to December 31, 2019
Conversion of Notes into common stock
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock resulting from exercise of stock options
from June 30, 2019 to September 30, 2019
Issuance of common stock under Employee Stock Purchase Plan
Issuance of common stock resulting from vesting of restricted stock units
Issuance of common stock resulting from exercise of stock options
from December 31, 2018 to March 31, 2019
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units and payment of tax withholdings
from December 31, 2017 to December 31, 2018
Issuance of common stock resulting from follow-on offering, net of issuance costs of $361
Issuance of common stock resulting from at-the-market transactions, net of issuance costs of $0
Issuance of common stock resulting from exercise of stock options
from December 31, 2016 to December 31, 2017
Issuance of common stock resulting from follow-on offering, net of issuance costs of $324
Issuance of common stock resulting from at-the-market transactions, net of issuance costs of $112
Issuance of common stock resulting from exercise of stock options
from December 31, 2015 to December 31, 2016
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units and payment of tax withholdings
From December 31, 2014 to December 31, 2015
Issuance of common stock resulting from follow-on offering
Issuance of common stock resulting from at-the-market transactions, net of issuance costs of $53
Vesting of restricted stock
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units and payment of tax withholdings
In January 2015, we completed a follow-on offering in which we sold 8,337,500 shares of our common stock to the public at a price of $6.50 per share, including 1,087,500 shares issued pursuant to the exercise of the underwriters' option to purchase additional shares. The net proceeds from this offering were approximately $50.9 million, after deducting underwriting discounts and commissions.
from December 31, 2013 to December 31, 2014
Issuance of common stock, net of issuance costs of $43
Vesting of restricted stock
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units and payment of tax withholdings
Shares issued for technology rights
from December 31, 2012 to December 31, 2013
Issuance of common stock, net of issuance costs of $235
Vesting of restricted stock
Issuance of common stock resulting from exercise of stock options
Issuance of common stock resulting from vesting of restricted stock units and payment of tax withholdings
from December 31, 2011 to December 31, 2012
Conversion of redeemable convertible preferred stock into common stock
Issuance of common stock, net of issuance costs of $1,984
Issuance of common stock in exchange for license
Vesting of restricted stock
Issuance of common stock resulting from exercise of stock options
In January 2012, the Company's board of directors and stockholders approved a one-for-3.5 reverse stock split of the Company's common stock. The reverse stock split became effective on January 10, 2012.
1.the automatic conversion of all outstanding shares of our preferred stock into an aggregate of 11,740,794 shares of our common stock upon the closing of this offering;
2.all information in this prospectus gives effect to the one-for-3.5 reverse stock split of our common stock that was effected on January 10, 2012.
from December 31, 2010 to December 31, 2011
Issuance of Series A redeemable convertible preferred stock
Issuance of Series B redeemable convertible preferred stock, net of offering costs of $113
Accretion of redeemable convertible preferred stock to redemption value
Vesting of restricted stock